Nicotine Transdermal System Patch Step 2 14 mg/24h
Nicotine Transdermal System Patch · PATCH, EXTENDED RELEASE · BluePoint Laboratories
Nicotine Transdermal System Patch Step 2 is a patch, extended release containing nicotine transdermal system patch at 14 mg/24h, taken transdermal. Manufactured by BluePoint Laboratories.
Key Facts
- Brand Name
- Nicotine Transdermal System Patch Step 2
- Generic Name
- Nicotine Transdermal System Patch
- NDC Code (Product)
68001-698- Manufacturer
- BluePoint Laboratories
- Strength
- 14 mg/24h
- Dosage Form
- PATCH, EXTENDED RELEASE
- Route
- TRANSDERMAL
- Marketing Status
- Application #
- NDA020076
- Drug Class
- Cholinergic Nicotinic Agonist [EPC]
- Marketing Start
- 05/11/2026
Recall History
No Recall HistorySide Effects Reported to FDA
FDA FAERS database · These are reported events, not confirmed side effects
Frequently Asked Questions
What is Nicotine Transdermal System Patch Step 2 used for?
Nicotine Transdermal System Patch Step 2 contains Nicotine Transdermal System Patch. It is a patch, extended release taken transdermal. Consult your doctor for specific uses.
Is Nicotine Transdermal System Patch Step 2 a controlled substance?
Nicotine Transdermal System Patch Step 2 is not classified as a controlled substance by the DEA.
What is the generic name for Nicotine Transdermal System Patch Step 2?
The generic name for Nicotine Transdermal System Patch Step 2 is Nicotine Transdermal System Patch. There are 5 other brand versions of Nicotine Transdermal System Patch.
What is the NDC code for Nicotine Transdermal System Patch Step 2 14 mg/24h?
The NDC (National Drug Code) for Nicotine Transdermal System Patch Step 2 14 mg/24h is 68001-698, listed by BluePoint Laboratories.